PP
CYTK icon

PDT Partners’s Cytokinetics CYTK Stock Holding History

PDT Partners’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,326
Closed -$923K – 564
2023
Q3 		$923K Sell
31,326
-56,403
-64% -$1.88M 0.12% 302
2023
Q2 		$2.86M Sell
87,729
-112
-0.1% -$4.14K 0.39% 62
2023
Q1 		$3.09M Buy
87,841
+44,294
+102% +$1.81M 0.42% 71
2022
Q4 		$2M Buy
+43,547
New +$1.87M 0.32% 78
2020
Q2 		– Sell
-102,200
Closed -$1.21M – 697
2020
Q1 		$1.21M Buy
102,200
+22,800
+29% +$291K 0.1% 210
2019
Q4 		$842K Buy
79,400
+30,400
+62% +$312K 0.05% 314
2019
Q3 		$558K Sell
49,000
-7,122
-13% -$89.4K 0.03% 332
2019
Q2 		$631K Sell
56,122
-7,309
-12% -$70.5K 0.04% 286
2019
Q1 		$513K Buy
63,431
+27,978
+79% +$206K 0.03% 315
2018
Q4 		$224K Buy
35,453
+48
+0.1% +$352 0.01% 390
2018
Q3 		$349K Sell
35,405
-9,595
-21% -$77K 0.01% 395
2018
Q2 		$374K Buy
+45,000
New +$374K 0.01% 425
2016
Q1 		– Sell
-171,000
Closed -$1.79M – 568
2015
Q4 		$1.79M Sell
171,000
-24,800
-13% -$243K 0.25% 156
2015
Q3 		$1.31M Buy
195,800
+36,300
+23% +$248K 0.03% 629
2015
Q2 		$1.07M Buy
159,500
+85,900
+117% +$563K 0.03% 723
2015
Q1 		$499K Buy
+73,600
New +$550K 0.01% 1013
2013
Q4 		– Sell
-36,083
Closed -$274K – 741
2013
Q3 		$274K Buy
+36,083
New +$387K 0.01% 1282

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

PDT Partners's CYTK Position: Q4 2023 in Review

PDT Partners sold out of Cytokinetics (CYTK) in Q4 2023, closing a stake of 31,326 shares — an estimated $923K sold.

PDT Partners first reported a position in CYTK in Q3 2013 and held it in 17 quarters. The position peaked at $3.09M in Q1 2023. 347 funds tracked by Wall St. Rank hold CYTK as of Q4 2023.

  • PDT Partners reported no remaining Cytokinetics position as of Q4 2023 after selling out during the quarter.
  • PDT Partners sold 31,326 Cytokinetics shares in Q4 2023, an estimated $923K.
  • PDT Partners first reported a position in Cytokinetics in Q3 2013 and held it in 17 quarters.
  • PDT Partners's Cytokinetics position peaked at $3.09M in Q1 2023.
  • 347 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2023.

Based on PDT Partners's 13F filing for Q4 2023, filed 14 Feb 2024.